Wayne Batchelor, MD, is an interventional cardiologist and structural heart specialist who serves as President of the Medicine Service Line at Inova Health System, where he is also Associate Director of Inova Schar Heart and Vascular and leads interventional cardiology research, innovation, and education. He is an Adjunct Professor of Medicine at Duke University School of Medicine and a Special Government Employee and consultant to the FDA’s cardiovascular devices program. Dr. Batchelor’s clinical practice centers on advanced catheter-based cardiovascular therapies, including complex coronary intervention, transcatheter structural heart procedures, and endovascular treatment of peripheral and carotid vascular disease. His research interests focus on cardiovascular outcomes and quality, health equity and clinical trial diversity, and regulatory science and data-driven evaluation of cardiovascular technologies. He holds national leadership roles including Chair of the American College of Cardiology Interventional Sectional Leadership Council and Vice-Chair of the STS/ACC TVT Registry Steering Committee, and serves on the Heart Valve Collaboratory Steering Committee. He contributes extensively to scientific publishing and peer review, including editorial board service for Circulation, JSCAI, and Cardiovascular Revascularization Medicine, and has served as a Guest Editor for a JSCAI issue focused on health equity in interventional cardiology. He earned his MD from Queen’s University Faculty of Medicine and completed additional graduate training with an MHS in Clinical Research from Duke University and an Executive MBA from New York University.
Hospital Leadership
Medical School
1986 – 1990
Residency
1990 – 1993
Fellowship
1993 – 1995